Medi Assist Makes Q3 FY26 Earnings Call Recording Available Following Strong Results
Medi Assist Healthcare Services Limited reported strong Q3 FY26 performance with 24% revenue growth and debt-free status from January 2026. The company has made available its earnings call recording from February 09, 2026, discussing unaudited results for the quarter and nine months ended December 31, 2025, in compliance with SEBI regulations.

*this image is generated using AI for illustrative purposes only.
Medi Assist Healthcare Services Limited reported strong financial performance for Q3 and nine-month period FY26, achieving 24% year-on-year revenue growth and becoming debt-free from January 2026. Following the results announcement, the company has made available the audio recording of its earnings call held on February 09, 2026.
Strong Financial Performance and Debt-Free Achievement
The company demonstrated robust growth with operating revenue increasing 24.0% year-on-year for the nine-month period. EBITDA reached 21.7% (excluding Paramount), while standalone Paramount TPA showed remarkable improvement with margins expanding 557 basis points quarter-on-quarter.
| Financial Metric (9M FY26): | Performance |
|---|---|
| Operating Revenue Growth: | +24.0% YoY |
| EBITDA: | 21.7% (ex-Paramount) |
| Free Cash: | ₹200.1 Cr |
| Debt Status: | Debt-free from Jan 2026 |
| Adjusted PAT: | ₹46.3 Cr (excluding exceptions) |
The company achieved debt-free status by reducing debt from previous levels to ₹39.4 Cr as of December 2025, and completely eliminating debt from January 2026 onwards, strengthening its balance sheet position.
Market Share Expansion and Premium Growth
Medi Assist continued to expand its market presence with total Group and Retail premiums administered growing 21.9% year-on-year to ₹19,298.1 Cr. The company's market share of Group and Retail premiums under administration increased to 21.1%, representing an expansion of 133 basis points year-on-year.
| Market Performance: | Achievement |
|---|---|
| Premium Growth: | +21.9% YoY to ₹19,298.1 Cr |
| Group + Retail Market Share: | 21.1% (+133 bps YoY) |
| Group Market Share: | 32.2% (+307 bps YoY) |
| Total Claims Processed: | 72.91 Lakh |
The company processed 72.91 lakh claims during the period, including 17.22 lakh cashless inpatient claims, 9.80 lakh reimbursement inpatient claims, 18.22 lakh cashless outpatient claims, and 27.67 lakh reimbursement outpatient claims.
Technology Platform Performance
Medi Assist's proprietary technology offerings showed exceptional growth with revenues increasing 81.5% year-on-year. The company's AI-powered platforms continued to demonstrate strong performance across key metrics.
| Technology Platform: | Performance Indicators |
|---|---|
| MAven Guard: | Flagged ~₹400 Cr potential fraud (+65.9% YoY) |
| Raksha Prime: | ~35,000 patients monthly, zero-waiting across ~6,000 hospitals |
| MAgnum: | Hospital-facing digital platform for self-service activation |
MAven Guard and Raksha Prime now integrate as add-ons with legacy and proprietary systems, including insurers' captive claims processing centres, expanding the company's reach across the ecosystem.
Earnings Call Recording and Regulatory Compliance
Pursuant to Regulation 30 and Regulation 46(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has made available the audio recording of its earnings call held on February 09, 2026. The call discussed the unaudited financial results for the quarter and nine months ended December 31, 2025.
| Earnings Call Details: | Information |
|---|---|
| Call Date: | February 09, 2026 |
| Audio Link: | Available on company website |
| Discussion Focus: | Q3 and 9M FY26 unaudited results |
| Regulatory Compliance: | SEBI Regulations 30 and 46(2) |
The recording is accessible on the company's website, providing stakeholders with detailed insights into the financial performance and strategic developments discussed during the investor conference call.
Leadership Changes and Strategic Appointments
The Board appointed Ms. Sunita Rebecca Cherian as Additional Director (Non-Executive, Non-Independent Director) effective February 06, 2026. With over 30 years of experience across various functions, she will serve as Member of the Nomination & Remuneration Committee and Corporate Social Responsibility Committee.
| Leadership Update: | Details |
|---|---|
| New Director: | Ms. Sunita Rebecca Cherian |
| Effective Date: | February 06, 2026 |
| Committee Roles: | Nomination & Remuneration, CSR |
| Outgoing Director: | Ms. Himani Atul Kapadia (March 14, 2026) |
Ms. Himani Atul Kapadia will complete her second and final term as Independent Director on March 14, 2026. The Board also approved the transfer of Paramount TPA business to Medi Assist TPA, effective February 1, 2026, ensuring operational continuity and seamless service delivery.
Historical Stock Returns for Medi Assist Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.26% | -9.45% | -11.35% | -31.67% | -19.39% | -19.72% |


































